Tero Satomaa

Summary

Publications

  1. doi request reprint Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens
    Tero Satomaa
    Glykos Finland Ltd, Helsinki, Finland
    Cancer Res 69:5811-9. 2009
  2. pmc The N-glycome of human embryonic stem cells
    Tero Satomaa
    Glykos Finland Ltd, Helsinki, Finland
    BMC Cell Biol 10:42. 2009
  3. doi request reprint Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage
    Annamari Heiskanen
    Glykos Finland Ltd, Helsinki, Finland
    Glycoconj J 26:367-84. 2009
  4. doi request reprint Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells
    Johanna Nystedt
    Advanced Therapies and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells 31:317-26. 2013
  5. ncbi request reprint N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells
    Heidi Hemmoranta
    Finnish Red Cross Blood Service, Research and Development, Helsinki, Finland
    Exp Hematol 35:1279-92. 2007
  6. doi request reprint Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms
    Johanna Nystedt
    Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells 28:258-67. 2010
  7. doi request reprint The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells
    Tia Hirvonen
    Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells Dev 21:455-64. 2012
  8. doi request reprint Lectin from Erythrina cristagalli supports undifferentiated growth and differentiation of human pluripotent stem cells
    Milla Mikkola
    Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
    Stem Cells Dev 22:707-16. 2013
  9. ncbi request reprint N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible
    Annamari Heiskanen
    Glykos Finland Ltd, Helsinki, Finland
    Stem Cells 25:197-202. 2007
  10. ncbi request reprint O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition
    Tero Satomaa
    Institute of Biotechnology and Department of Biosciences, Biomedicum and Haartman Institute, Haartmaninkatu 8, SF 00014 University of Helsinki, Helsinki, Finland
    Blood 99:2609-11. 2002

Collaborators

Detail Information

Publications10

  1. doi request reprint Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens
    Tero Satomaa
    Glykos Finland Ltd, Helsinki, Finland
    Cancer Res 69:5811-9. 2009
    ..In conclusion, the identified terminal GlcNAc glycans should be recognized as a novel class of tumor markers...
  2. pmc The N-glycome of human embryonic stem cells
    Tero Satomaa
    Glykos Finland Ltd, Helsinki, Finland
    BMC Cell Biol 10:42. 2009
    ..Structural analyses were performed by specific glycosidase enzymes and mass spectrometric fragmentation analyses...
  3. doi request reprint Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage
    Annamari Heiskanen
    Glykos Finland Ltd, Helsinki, Finland
    Glycoconj J 26:367-84. 2009
    ..Characteristic glycosylation features that appeared in differentiated osteoblasts included abundant sulfate ester modifications. The results show that glycosylation analysis can be used to evaluate MSC differentiation state...
  4. doi request reprint Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells
    Johanna Nystedt
    Advanced Therapies and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells 31:317-26. 2013
    ..Future studies should aim at developing methods of transiently modifying the cell surface structures in order to improve the delivery of therapeutic cells...
  5. ncbi request reprint N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells
    Heidi Hemmoranta
    Finnish Red Cross Blood Service, Research and Development, Helsinki, Finland
    Exp Hematol 35:1279-92. 2007
    ..Cell surface glycans contribute to the adhesion capacity of cells and are essential in cellular signal transduction. Yet, the glycosylation of hematopoietic stem and progenitor cells (HSPC), such as CD133+ cells, is poorly explored...
  6. doi request reprint Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms
    Johanna Nystedt
    Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells 28:258-67. 2010
    ..These results add further emphasis to the crucial need for completely xenofree culturing conditions for human stem cells...
  7. doi request reprint The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells
    Tia Hirvonen
    Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland
    Stem Cells Dev 21:455-64. 2012
    ..Based on these findings, we suggest that linear poly-N-acetyllactosamine could be used as a novel UCB-MSC marker either alone or within an array of MSC markers...
  8. doi request reprint Lectin from Erythrina cristagalli supports undifferentiated growth and differentiation of human pluripotent stem cells
    Milla Mikkola
    Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
    Stem Cells Dev 22:707-16. 2013
    ..Therefore, our findings indicate that lectins are potential candidates for design of culture and differentiation methods, and that ECA is a potent simple defined matrix for human pluripotent stem cells...
  9. ncbi request reprint N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible
    Annamari Heiskanen
    Glykos Finland Ltd, Helsinki, Finland
    Stem Cells 25:197-202. 2007
    ..Definition of safe culture conditions for stem cells is essential for future development of cellular therapies...
  10. ncbi request reprint O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition
    Tero Satomaa
    Institute of Biotechnology and Department of Biosciences, Biomedicum and Haartman Institute, Haartmaninkatu 8, SF 00014 University of Helsinki, Helsinki, Finland
    Blood 99:2609-11. 2002
    ..However, if sulfo sLex glycans are supplemented with separate sulfated, nonfucosylated O-glycans, saccharides in O-6, O-8, or O-9, putatively carrying MECA-79 epitopes, could form multiglycan binding epitopes for L-selectin...